Dr. Frederick Greene, our Chief Medical Officer has leveraged his extensive surgical experience and his ongoing editorial experiences with the AJCC and CoC to drive several initiatives for ERS - including the industry's first podcast focused on Cancer Registry.
Each year we frequently hear that a word, color, or child’s name is chosen as the leading example and most frequently used in each of these categories. It is certainly true that when it comes to “cancer theories” over the last two or three years, the term “microbiome” is the winner. The concept is that […]
March is “Colorectal Cancer Awareness Month” so it is appropriate to include some clinical facet of this malignancy in this month’s “Clinical Corner.” All of us will see many scientific reports and articles in the lay press this month that highlight the importance of colorectal malignancy. It is imperative to remember and promote the truism […]
Advances in precision medicine are taking place at an unprecedented rate. Precision medicine is defined by the NIH as "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow the development of screening, treatment and prevention strategies for a […]
Early in the COVID-19 pandemic, I wrote an editorial for the Annals of Surgical Oncology to challenge our clinicians and registry communities to create codes and other applications that would capture data relating to coronavirus infection in our cancer patients. I was delighted that our cancer registrars throughout the United States answered the challenge using […]
On December 23, 1971, 50 years ago this month, President Richard Nixon signed into law the National Cancer Act, heralding our National Cancer Program and the “War on Cancer.” As a result of this legislation, the National Cancer Institute (NCI) was strengthened, NCI-designated cancer centers were created, the cancer clinical trials network was expanded and […]
